Bacterial photodynamic inactivation mediated by methylene blue and red light is enhanced by synergistic effect of potassium iodide

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 9, 2015, Pages 5203-5212

  Vecchio, Daniela ^a,b   Gupta, Asheesh ^a,b,c   Huang, Liyi ^a,b,d   Landi, Giacomo ^a,e   Avci, Pinar ^a,b,f   Rodas, Andrea ^a,b,g   Hamblina, Michael R ^a,b,h  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

^d GUANGXI MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF SIENA   (Italy)

^f SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^g INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

^h HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; METHYLENE BLUE; PHOTOSENSITIZING AGENT; POTASSIUM IODIDE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE;

ADULT; AMPUTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BURN; BURN INFECTION; CONTROLLED STUDY; DEATH; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; LIFESPAN; MOUSE; NONHUMAN; PATIENT CARE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; RED LIGHT; RISK ASSESSMENT; WOUND; CHEMISTRY; DRUG EFFECTS; LIGHT; METABOLISM; RADIATION RESPONSE; STAPHYLOCOCCUS AUREUS;

LIGHT; METHYLENE BLUE; PHOTOSENSITIZING AGENTS; POTASSIUM IODIDE; REACTIVE OXYGEN SPECIES; STAPHYLOCOCCUS AUREUS;

EID: 84940502770     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00019-15     Document Type: Article

References (28)

1. st century. Perspect Medicin Chem 6:25-64.
2. Hamblin MR, Hasan T. 2004. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci 3:436-450. http://dx.doi.org/10.1039/b311900a.
3. Garland MJ, Cassidy CM, Woolfson D, Donnelly RF. 2009. Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments. Future Med Chem 1:667- 691. http://dx.doi.org /10.4155/fmc.09.55.
4. Huang L, Xuan Y, Koide Y, Zhiyentayev T, Tanaka M, Hamblin MR. 2012. Type I and type II mechanisms of antimicrobial photodynamic ther-apy: an in vitro study on Gram-negative and Gram-positive bacteria. Lasers Surg Med 44:490-499. http://dx.doi.org/10.1002/lsm.22045.
5. Wan W, Yeow JT. 2012. Antibacterial properties of poly(quaternary ammonium) modified gold and titanium dioxide nanoparticles. J Nanosci Nanotechnol 12:4601-4606. http://dx.doi.org/10.1166/jnn.2012.6147.
6. Marotti J, Sperandio FF, Fregnani ER, Aranha AC, de Freitas PM, Eduardo CDP. 2010. High-intensity laser and photodynamic therapy as a treatment for recurrent herpes labialis. Photomed Laser Surg 28:439-444. http://dx.doi.org/10.1089/pho.2009.2522.
7. Sperandio FF, Marotti J, Aranha AC, Eduardo CDP. 2009. Photodynamic therapy for the treatment of recurrent herpes labialis: preliminary results. Gen Dent 57:415-419.
8. de Oliveira BP, Aguiar CM, Camara AC. 2014. Photodynamic therapy in combating the causative microorganisms from endodontic infections. Eur J Dent 8:424 - 430. http://dx.doi.org/10.4103/1305-7456.137662.
9. Klepac-Ceraj V, Patel N, Song X, Holewa C, Patel C, Kent R, Amiji MM, Soukos NS. 2011. Photodynamic effects of methylene blue-loaded polymeric nanoparticles on dental plaque bacteria. Lasers Surg Med 43: 600-606.
10. Siddiqui SH, Awan KH, Javed F. 2013. Bactericidal efficacy of photodynamic therapy against Enterococcus faecalis in infected root canals: a systematic literature review. Photodiagnosis Photodyn Ther 10:632- 643. http://dx.doi.org/10.1016/j.pdpdt.2013.07.006.
11. Huang L, St Denis TG, Xuan Y, Huang YY, Tanaka M, Zadlo A, Sarna T, Hamblin MR. 2012. Paradoxical potentiation of methylene bluemediated antimicrobial photodynamic inactivation by sodium azide: role of ambient oxygen and azide radicals. Free Radic Biol Med 53:2062-2071. http://dx.doi.org/10.1016/j.freeradbiomed.2012.09.006.
12. St Denis TG, Vecchio D, Zadlo A, Rineh A, Sadasivam M, Avci P, Huang L, Kozinska A, Chandran R, Sarna T, Hamblin MR. 2013. Thiocyanate potentiates antimicrobial photodynamic therapy: in situ generation of the sulfur trioxide radical anion by singlet oxygen. Free Radic Biol Med 65:800 - 810. http://dx.doi.org/10.1016/j.freeradbiomed.2013 .08.162.
13. Food and Drug Administration. 2001. Guidance on potassium iodide as a thyroid blocking agent in radiation emergencies. Food and Drug Administration, Washington, DC.
14. Hassan I, Keen A. 2012. Potassium iodide in dermatology. Indian J Dermatol Venereol Leprol 78:390 -393. http://dx.doi.org/10.4103/0378 -6323.95472.
15. st century-uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol 43:691-697. http://dx .doi.org/10.1067/mjd.2000.107247.
16. Costa RO, Macedo PM, Carvalhal A, Bernardes-Engemann AR. 2013. Use of potassium iodide in dermatology: updates on an old drug. An Bras Dermatol 88:396 - 402. http://dx.doi.org/10.1590/abd1806 -4841.20132377.
17. Dai T, Gupta A, Huang YY, Sherwood ME, Murray CK, Vrahas MS, Kielian T, Hamblin MR. 2013. Blue light eliminates communityacquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. Photomed Laser Surg 31:531-538. http://dx.doi.org/10 .1089/pho.2012.3365.
18. Miyachi Y, Niwa Y. 1982. Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocyte-derived oxygen intermediates. Br J Dermatol 107:209-214. http://dx.doi.org/10 .1111/j.1365-2133.1982.tb00340.x.
19. Gebicki JM, Guille J. 1989. Spectrophotometric and highperformance chromatographic assays of hydroperoxides by the iodometric technique. Anal Biochem 176:360-364. http://dx.doi.org/10 .1016/0003-2697(89)90323-0.
20. Klebanoff SJ. 1982. The iron-H2 O2 -iodide cytotoxic system. J Exp Med 156:1262-1267. http://dx.doi.org/10.1084/jem.156.4.1262.
21. Levitz SM, Diamond RD. 1984. Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system. Infect Immun 43:1100-1102.
22. Sugar AM, Chahal RS, Brummer E, Stevens DA. 1984. The ironhydrogen peroxide-iodide system is fungicidal: activity against the yeast phase of Blastomyces dermatitidis. J Leukoc Biol 36:545-548.
23. Klebanoff SJ. 1967. Iodination of bacteria: a bactericidal mechanism. J Exp Med 126:1063-1078. http://dx.doi.org/10.1084/jem.126.6.1063.
24. Ihalin R, Nuutila J, Loimaranta V, Lenander M, Tenovuo J, Lilius EM. 2003. Susceptibility of Fusobacterium nucleatum to killing by peroxidase-iodide-hydrogen peroxide combination in buffer solution and in human whole saliva. Anaerobe 9:23-30. http://dx.doi.org/10.1016/S1075 -9964(03)00005-2.
25. Kohler H, Jenzer H. 1989. Interaction of lactoperoxidase with hydrogen peroxide. Formation of enzyme intermediates and generation of free radicals. Free Radic Biol Med 6:323-339.
26. Chance B. 1999. The kinetics of the enzyme-substrate compound of peroxidase. 1943. Adv Enzymol Relat Areas Mol Biol 73:3-23.
27. Vanden Abbeele A, De Meel H, Courtois P, Pourtois M. 1996. Influence of a hypoiodite mouth-wash on dental plaque formation in vivo. Bull Group Int Rech Sci Stomatol Odontol 39:57-61.
28. Bosch EH, van Doorne H, de Vries S. 2000. The lactoperoxidase system: the influence of iodide and the chemical and antimicrobial stability over the period of about 18 months. J Appl Microbiol 89:215-224. http://dx .doi.org/10.1046/j.1365-2672.2000.01098.x.